You may have heard of Nexvax2, the “celiac vaccine” currently undergoing clinical trials in the US and around the world. (If you haven't, read this announcement.) It’s an exciting breakthrough, and one that has been more than 20 years in the making.
To offer some perspective, Bob Anderson, MBChB, PhD, FRACP, Chief Scientific Officer at ImmunsanT, Inc, the pharmaceutical company behind NexVax2, wrote an article explaining the history and research findings that led to the development of this potential vaccine.
To get a glimpse of the process that led scientists to where they are today, read:
Transforming celiac disease from a digestive disease to an immune disease: and restoring tolerance to gluten in celiac disease
Note: NFCA maintains the position that views and information presented on articles and websites we link to are those of the authors, and not necessarily those of NFCA.
PATIENT INFORMATION
Do You Have Celiac Disease? Celiac Symptoms Checklist
Already Diagnosed? Celiac Resources
TRAINING & EDUCATION
Health Care Professionals Celiac CME Central
Food Industry Professionals GREAT Foodservice
Patients & Professionals Free Webinars
CELIAC LIVING
Celiac Diet Information Guides and Resources
Gluten-Free Cooking Recipes & Meal Ideas
Celiac Shop Celiac Books and Products
NEWS & UPDATES
News Feeds & Blogs Celiac Central Newsletter
CONNECT WITH NFCA
Advertisement Consumer Advertising Disclaimer